C85.99 Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
• ICD Code: C85.99

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in extranodal or solid organ sites (outside of lymph nodes). The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes (neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal pain or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes
• Organ-specific symptoms (e.g., abdominal pain if affecting the gastrointestinal tract)

Diagnosis

Diagnosis typically involves a combination of physical examination, blood tests, imaging scans (CT, MRI, PET), and tissue biopsy of the affected organ or site. Pathology reports confirm the presence of lymphoma and help determine the subtype and extent of disease.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells.
• Radiation therapy: Targets specific areas to reduce tumor size.
• Immunotherapy: Boosts the immune system to fight cancer.
• Targeted therapy: Targets specific cancer cell characteristics.
• Stem cell transplant: Replaces damaged bone marrow with healthy cells.

Prognosis and Follow-Up

Prognosis depends on factors like age, overall health, and disease stage. Regular follow-up with imaging, blood tests, and physical exams is essential to monitor for recurrence or progression. Treatment response and long-term outcomes vary by individual.

Complications

• Recurrence of lymphoma
• Infection due to weakened immune system
• Organ damage from tumor growth
• Side effects from treatment (e.g., fatigue, nausea)
• Secondary cancers

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known carcinogens (e.g., tobacco, excessive alcohol).
• Manage chronic infections or immune disorders with medical care.
• Stay up-to-date with vaccinations (e.g., flu, pneumonia) as recommended.

When to Seek Professional Help

Seek medical attention for persistent symptoms like unexplained weight loss, fever, night sweats, or swollen lymph nodes. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

Use C85.99 when documentation specifies non-Hodgkin lymphoma in extranodal or solid organ sites without a defined subtype. Ensure the site is clearly documented (e.g., gastrointestinal tract, skin, or other organs) to support code assignment. Verify that "unspecified" applies to both the subtype and site to avoid miscoding.